UK-based MedPharm, an Ampersand Capital Partners portfolio company, and the US firm Tergus Pharma, a Great Point Partners portfolio company, have jointly announced they are merging.
Investment in artificial intelligence (AI) is on the increase in the pharma industry due to its capacity to drive efficiencies and innovation. 1 June 2022
Bruised by its failure to enter the superlatively lucrative market for coronavirus shots, British drug developer GlaxoSmithKline (LSE: GSK) is to spend billions 31 May 2022
Building on a licensing deal with AstraZeneca, British biotech RQ Bio has announced its launch, with a focus on developing antibody treatments and preventive th 17 May 2022
Investment company eureKARE, which is focused on financing and building biotech companies in the disruptive fields of synthetic biology and the microbiome, has 12 May 2022
Tokyo’s Taiho Pharmaceutical, a business of Japanese drug major Otsuka Pharmaceutical, has agreed to buy part of Cullinan Oncology, thereby regaining rights to 12 May 2022